Nefrologia

Clinical, pathological, and genetic characteristics of cases with asymptomatic proteinuria not manifesting nephrotic syndrome at onset: a single-center retrospective study.

Clinical and experimental nephrology. 2022 May; 26(May):453-459. doi: 10.1007/s10157-021-02174-w. pii: .

Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE Trial.

Clinical journal of the American Society of Nephrology : CJASN. 2025 May; 20(May):706-718. doi: 10.2215/CJN.0000000659. pii: .

Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network.

Clinical journal of the American Society of Nephrology : CJASN. 2025 May; 20(May):697-705. doi: 10.2215/CJN.0000000671. pii: .

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline.

Annals of internal medicine. 2025 May; 178(May):705-713. doi: 10.7326/ANNALS-24-01926. pii: .

Nephrotic Syndrome Thromboprophylaxis With Direct Oral Anticoagulants or Vitamin K Antagonists.

Kidney international reports. 2025 May; 10(May):1468-1475. doi: 10.1016/j.ekir.2025.02.028. pii: .

The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury.

American journal of physiology. Renal physiology. 2025 May; 328(May):F647-F661. doi: 10.1152/ajprenal.00173.2024. pii: .

ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury.

Journal of the American Society of Nephrology : JASN. 2025 May; 36(May):926-939. doi: 10.1681/ASN.0000000646. pii: .

Efficacy and safety of rituximab in primary IgA nephropathy: a retrospective study.

Clinical and experimental nephrology. 2025 May; 29(May):616-623. doi: 10.1007/s10157-024-02617-0. pii: .

Methods for Diagnosing Proteinuria-When to Use Which Test and Why: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2025 May; 85(May):618-628. doi: 10.1053/j.ajkd.2024.09.017. pii: S0272-6386(24)01124-7.

Associations of Topiramate and Zonisamide Use With Kidney Stones: A Retrospective Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2025 Jun; 85(Jun):687-694.e1. doi: 10.1053/j.ajkd.2024.12.009. pii: S0272-6386(25)00705-X.

Liberation from pediatric continuous kidney replacement therapy: a survey of provider perceptions and practices.

Pediatric nephrology (Berlin, Germany). 2025 Jun; doi: 10.1007/s00467-025-06849-4. pii: .

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.

The New England journal of medicine. 2025 Jun; doi: 10.1056/NEJMoa2410659. pii: .

Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2025 Feb; 40(Feb):i3-i17. doi: 10.1093/ndt/gfae212. pii: .

The New Cardiovascular-Kidney-Metabolic (CKM) Syndrome: An Opportunity for CKD Detection and Treatment in Primary Care.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2025 Apr; 85(Apr):399-402. doi: 10.1053/j.ajkd.2024.09.016. pii: S0272-6386(24)01121-1.

Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases.

Clinical kidney journal. 2025 May; 18(May):sfaf100. doi: 10.1093/ckj/sfaf100. pii: sfaf100.

Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?

Antibodies (Basel, Switzerland). 2025 Mar; 14(Mar):doi: 10.3390/antib14010025. pii: 25.

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

The New England journal of medicine. 2025 Feb; 392(Feb):777-787. doi: 10.1056/NEJMoa2409183. pii: .

Effects of aging on chronic kidney disease mineral and bone disorder.

Current opinion in nephrology and hypertension. 2025 May; doi: 10.1097/MNH.0000000000001084. pii: .

The intelligent podocyte: sensing and responding to a complex microenvironment.

Nature reviews. Nephrology. 2025 May; doi: 10.1038/s41581-025-00965-y. pii: .

Autosomal Dominant Polycystic Kidney Disease: A Review.

JAMA. 2025 May; 333(May):1708-1719. doi: 10.1001/jama.2025.0310. pii: .

The Value of Second-look Ultrasound and Mammography for Assessment and Biopsy of MRI-detected Breast Lesions.

Academic radiology. 2025 Apr; 32(Apr):1818-1826. doi: 10.1016/j.acra.2024.10.037. pii: S1076-6332(24)00826-2.

The Kidney and Extracorporeal Therapies in Acute-on-Chronic Liver Failure: What the Nephrologist Needs to Know.

Nephrology (Carlton, Vic.). 2025 Apr; 30(Apr):e70034. doi: 10.1111/nep.70034. pii: .

The current status of biomarkers for bladder cancer: progress and challenges.

Minerva urology and nephrology. 2025 Apr; 77(Apr):149-151. doi: 10.23736/S2724-6051.25.06372-4. pii: .

Treatment of patients with IgA nephropathy: a call for a new paradigm.

Kidney international. 2025 Apr; 107(Apr):640-651. doi: 10.1016/j.kint.2025.01.014. pii: S0085-2538(25)00076-6.

Syndrome of Inappropriate Antidiuresis.

Journal of the American Society of Nephrology : JASN. 2025 Apr; 36(Apr):713-722. doi: 10.1681/ASN.0000000588. pii: .

Management of genetically determined kidney stone disease: consensus from a panel of urologists and nephrologists.

Minerva urology and nephrology. 2025 Feb; 77(Feb):130-136. doi: 10.23736/S2724-6051.24.05875-0. pii: .

KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Kidney international. 2025 Feb; 107(Feb):S1-S239. doi: 10.1016/j.kint.2024.07.009. pii: S0085-2538(24)00479-4.

I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology.

Jornal brasileiro de nefrologia. 2025 ; 47():e20240033. doi: 10.1590/2175-8239-JBN-2024-0033en. pii: e20240033.

Recommendations for diagnosis and treatment of Atypical Hemolytic Uremic Syndrome (aHUS): an expert consensus statement from the Rare Diseases Committee of the Brazilian Society of Nephrology (COMDORA-SBN).

Jornal brasileiro de nefrologia. 2025 ; 47():e20240087. doi: 10.1590/2175-8239-JBN-2024-0087en. pii: e20240087.

Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology.

Kidney international. 2025 Jan; 107(Jan):21-32. doi: 10.1016/j.kint.2024.09.017. pii: S0085-2538(24)00724-5.

Light-chain (AL) amyloidosis for nephrologists-treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024 Dec; 40(Dec):34-47. doi: 10.1093/ndt/gfae224. pii: .

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024 Sep; 39(Sep):1583-1592. doi: 10.1093/ndt/gfae162. pii: .

Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024 Sep; 39(Sep):1710-1730. doi: 10.1093/ndt/gfae075. pii: .

Clinical practice guideline for the prevention and management of peritoneal dialysis associated infections in children: 2024 update.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis. 2024 Sep; 44(Sep):303-364. doi: 10.1177/08968608241274096. pii: .

Iohexol plasma clearance measurement protocol standardization for adults: a consensus paper of the European Kidney Function Consortium.

Kidney international. 2024 Oct; 106(Oct):583-596. doi: 10.1016/j.kint.2024.06.029. pii: S0085-2538(24)00537-4.

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.

BMJ (Clinical research ed.). 2024 Oct; 387(Oct):e080257. doi: 10.1136/bmj-2024-080257. pii: .

Clinical guideline on adequacy and prescription of peritoneal dialysis.

Nefrologia. 2024 Sep; 44 Suppl 1(Sep):1-27. doi: 10.1016/j.nefroe.2024.09.001. pii: S2013-2514(24)00172-X.

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

Kidney international. 2024 Apr; 105(Apr):S117-S314. doi: 10.1016/j.kint.2023.10.018. pii: S0085-2538(23)00766-4.

Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.

Kidney international. 2024 Apr; 105(Apr):684-701. doi: 10.1016/j.kint.2023.10.016. pii: S0085-2538(23)00764-0.

KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis.

Kidney international. 2024 Mar; 105(Mar):S71-S116. doi: 10.1016/j.kint.2023.10.008. pii: S0085-2538(23)00744-5.

KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.

Kidney international. 2024 Jan; 105(Jan):S1-S69. doi: 10.1016/j.kint.2023.09.002. pii: S0085-2538(23)00627-0.

Liberation from pediatric continuous kidney replacement therapy: a survey of provider perceptions and practices.

Pediatric nephrology (Berlin, Germany). 2025 Jun; doi: 10.1007/s00467-025-06849-4. pii: .

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.

The New England journal of medicine. 2025 Jun; doi: 10.1056/NEJMoa2410659. pii: .

Associations of Topiramate and Zonisamide Use With Kidney Stones: A Retrospective Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation. 2025 Jun; 85(Jun):687-694.e1. doi: 10.1053/j.ajkd.2024.12.009. pii: S0272-6386(25)00705-X.

Disease-modifying anti-nephropathic drugs (DMANDs)-a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA).

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2025 May; 40(May):1243-1247. doi: 10.1093/ndt/gfaf033. pii: .

Autosomal Dominant Polycystic Kidney Disease: A Review.

JAMA. 2025 May; 333(May):1708-1719. doi: 10.1001/jama.2025.0310. pii: .

The intelligent podocyte: sensing and responding to a complex microenvironment.

Nature reviews. Nephrology. 2025 May; doi: 10.1038/s41581-025-00965-y. pii: .

Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD).

Expert opinion on drug metabolism & toxicology. 2025 May; 1-11. doi: 10.1080/17425255.2025.2501127. pii: .

Effects of aging on chronic kidney disease mineral and bone disorder.

Current opinion in nephrology and hypertension. 2025 May; doi: 10.1097/MNH.0000000000001084. pii: .

APOL1-associated kidney disease: modulators of the genotype-phenotype relationship.

Current opinion in nephrology and hypertension. 2025 May; 34(May):191-198. doi: 10.1097/MNH.0000000000001068. pii: .

The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury.

American journal of physiology. Renal physiology. 2025 May; 328(May):F647-F661. doi: 10.1152/ajprenal.00173.2024. pii: .